Related references
Note: Only part of the references are listed.Knowledge, behaviors and practices of community and hospital pharmacists towards biosimilar medicines: Results of a French web-based survey
Morgane Beck et al.
MABS (2017)
Biosimilar biologic drugs: a new frontier in medical care
Daniel M. Geynisman et al.
POSTGRADUATE MEDICINE (2017)
Insights on the use of biosimilars in the treatment of inflammatory bowel disease
Michael K. Zheng et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Pricing and Reimbursement of Biosimilars in Central and Eastern European Countries
Pawel Kawalec et al.
FRONTIERS IN PHARMACOLOGY (2017)
What pricing and reimbursement policies to use for off-patent biologicals in Europe? - results from the second EBE biological medicines policy survey
Jean-Baptiste Reiland et al.
GABI JOURNAL-GENERICS AND BIOSIMILARS INITIATIVE JOURNAL (2017)
The changing landscape of biosimilars in rheumatology
Thomas Doerner et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
A survey among hospital specialists and pharmacists about biosimilars
Luca Pasina et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2016)
Postmarket policy considerations for biosimilar oncology drugs
Matthew J. Renwick et al.
LANCET ONCOLOGY (2016)
Patient attitudes and understanding about biosimilars: an international cross-sectional survey
Ira Jacobs et al.
PATIENT PREFERENCE AND ADHERENCE (2016)
Payers' Views of the Changes Arising through the Possible Adoption of Adaptive Pathways
Michael Ermisch et al.
Frontiers in Pharmacology (2016)
How Much Are Biosimilars Used in Clinical Practice? A Retrospective Italian Population-Based Study of Erythropoiesis-Stimulating Agents in the Years 2009-2013
Ylenia Ingrasciotta et al.
BIODRUGS (2015)
Are new models needed to optimize the utilization of new medicines to sustain healthcare systems?
Brian Godman et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2015)
What pricing and reimbursement policies to use for off-patent biologicals? - Results from the EBE 2014 biological medicines policy survey
Virginia Acha et al.
GABI JOURNAL-GENERICS AND BIOSIMILARS INITIATIVE JOURNAL (2015)
Can authorities appreciably enhance the prescribing of oral generic risperidone to conserve resources? Findings from across Europe and their implications
Brian Godman et al.
BMC MEDICINE (2014)
Analysis of Spanish generic medicines retail market: recommendations to enhance long-term sustainability
Pieter Dylst et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2014)
Personalizing health care: feasibility and future implications
Brian Godman et al.
BMC MEDICINE (2013)
Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers
Jakub Adamski et al.
BMC HEALTH SERVICES RESEARCH (2010)
Soft Regulations in Pharmaceutical Policy Making An Overview of Current Approaches and their Consequences
Bjorn Wettermark et al.
APPLIED HEALTH ECONOMICS AND HEALTH POLICY (2009)
Share Paper
